These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24729812)

  • 1. Clinical value of extended pelvic lymph node dissection in patients subjected to radical prostatectomy.
    Dobruch J; Piotrowicz S; Skrzypczyk M; Gołąbek T; Chłosta P; Borówka A
    Wideochir Inne Tech Maloinwazyjne; 2014 Mar; 9(1):64-70. PubMed ID: 24729812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
    Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
    Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection.
    Roscigno M; Nicolai M; La Croce G; Pellucchi F; Scarcello M; Saccà A; Angiolilli D; Chinaglia D; Da Pozzo LF
    Front Surg; 2018; 5():52. PubMed ID: 30246012
    [No Abstract]   [Full Text] [Related]  

  • 4. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy: a prospective, randomized trial.
    Harke NN; Godes M; Wagner C; Addali M; Fangmeyer B; Urbanova K; Hadaschik B; Witt JH
    World J Urol; 2018 Nov; 36(11):1817-1823. PubMed ID: 29767326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study.
    Vagnoni V; Schiavina R; Romagnoli D; Borghesi M; Passaretti G; Dababneh H; Concetti S; Martorana G
    Urologia; 2012 Dec; 79 Suppl 19():141-6. PubMed ID: 22865337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results.
    Lattouf JB; Beri A; Jeschke S; Sega W; Leeb K; Janetschek G
    Eur Urol; 2007 Nov; 52(5):1347-55. PubMed ID: 17507150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection.
    Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
    Clin Cancer Res; 2018 May; 24(10):2342-2349. PubMed ID: 29463560
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of semi-extended and standard lymph node dissection in radical prostatectomy: A single-institute experience.
    Hoshi S; Hayashi N; Kurota Y; Hoshi K; Muto A; Sugano O; Numahata K; Bilim V; Sasagawa I; Ohta S
    Mol Clin Oncol; 2015 Sep; 3(5):1085-1087. PubMed ID: 26623055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
    BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The learning curve for laparoscopic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer: implications for compliance with existing guidelines.
    Eden CG; Zacharakis E; Bott S
    BJU Int; 2013 Aug; 112(3):346-54. PubMed ID: 23419154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized and Simplified Robot-assisted Superextended Pelvic Lymph Node Dissection for Prostate Cancer: The Monoblock Technique.
    Mattei A; Würnschimmel C; Baumeister P; Hyseni A; Afferi L; Moschini M; Mordasini L; Grande P
    Eur Urol; 2020 Sep; 78(3):424-431. PubMed ID: 32327264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
    Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intermediate and high risk prostate cancer patients. Clinical significance of extended lymphadenectomy].
    Osmonov DK; Boller A; Aksenov A; Naumann M; Jünemann KP
    Urologe A; 2013 Feb; 52(2):240-5. PubMed ID: 23150089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undetectable PSA after radical prostatectomy is more likely in low burden N+ prostate cancer patients when an extended lymph node dissection is performed.
    Ramírez-Backhaus M; Mir Maresma MC; Mascarós JM; Bertolo R; Hernández J; Gómez Ferrer A; Casanova-Ramón Borja J; Domínguez Escrig JL; Collado-Serra A; Calatrava Fons A; Rubio-Briones J
    Actas Urol Esp (Engl Ed); 2019 Nov; 43(9):480-487. PubMed ID: 31174878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer.
    Gandaglia G; De Lorenzis E; Novara G; Fossati N; De Groote R; Dovey Z; Suardi N; Montorsi F; Briganti A; Rocco B; Mottrie A
    Eur Urol; 2017 Feb; 71(2):249-256. PubMed ID: 27209538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series.
    Godoy G; von Bodman C; Chade DC; Dillioglugil O; Eastham JA; Fine SW; Scardino PT; Laudone VP
    J Urol; 2012 Jun; 187(6):2082-6. PubMed ID: 22498221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph Node Fluorescence During Robot-Assisted Radical Prostatectomy With Indocyanine Green: Prospective Dosing Analysis.
    Chennamsetty A; Zhumkhawala A; Tobis SB; Ruel N; Lau CS; Yamzon J; Wilson TG; Yuh BE
    Clin Genitourin Cancer; 2017 Aug; 15(4):e529-e534. PubMed ID: 27939590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.
    Gakis G; Boorjian SA; Briganti A; Joniau S; Karazanashvili G; Karnes RJ; Mattei A; Shariat SF; Stenzl A; Wirth M; Stief CG
    Eur Urol; 2014 Aug; 66(2):191-9. PubMed ID: 23735200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.